Comparison of Patient Susceptibility Genes Across Breast Cancer: Implications for Prognosis and Therapeutic Outcomes

por Peleg Hasson, Shira, Menes, Tehillah, Sonnenblick, Amir
Publicado 2020

The History of Early Breast Cancer Treatment

por Ben-Dror, Judith, Shalamov, Michal, Sonnenblick, Amir
Publicado 2022

Coexistent ARID1A-PIK3CA mutations are associated with immune-related pathways in luminal breast cancer

por Anabel Sinberger, Liat, Zahavi, Tamar, Sonnenblick, Amir, Salmon‐Divon, Mali
Publicado 2023

pAKT pathway activation is associated with PIK3CA mutations and good prognosis in luminal breast cancer in contrast to p-mTOR pathway activation

por Sonnenblick, Amir, Venet, David, Brohée, Sylvain, Pondé, Noam, Sotiriou, Christos
Publicado 2019

Decoding cancer heterogeneity: studying patient-specific signaling signatures towards personalized cancer therapy

por Flashner-Abramson, Efrat, Vasudevan, Swetha, Adejumobi, Ibukun Adesoji, Sonnenblick, Amir, Kravchenko-Balasha, Nataly
Publicado 2019

Alpelisib Efficacy in Hormone Receptor-Positive HER2-Negative PIK3CA-Mutant Advanced Breast Cancer Post-Everolimus Treatment

por Raphael, Ari, Salmon-Divon, Mali, Epstein, Jessica, Zahavi, Tamar, Sonnenblick, Amir, Shachar, Shlomit S.
Publicado 2022

Heparanase augments insulin receptor signaling in breast carcinoma

por Goldberg, Rachel, Sonnenblick, Amir, Hermano, Esther, Hamburger, Tamar, Meirovitz, Amichay, Peretz, Tamar, Elkin, Michael
Publicado 2016

Impact of the OncotypeDX score and HER2 RNA PCR levels on HER2-low IHC levels in primary and metastasized tumors

por Feldman, Didi, Sinberger, Liat Anabel, Salmon-Divon, Mali, Ben-Dror, Judith, Shachar, Shlomit Strulov, Sonnenblick, Amir
Publicado 2023

SYK expression level distinguishes control from BRCA1-mutated lymphocytes

por Zahavi, Tamar, Sonnenblick, Amir, Shimshon, Yael, Kadouri, Luna, Peretz, Tamar, Salmon, Asher Y, Salmon-Divon, Mali
Publicado 2018

Sorafenib treatment during partial hepatectomy reduces tumorgenesis in an inflammation-associated liver cancer model

por Zahavi, Tamar, Lanton, Tali, Divon, Mali Salmon, Salmon, Asher, Peretz, Tamar, Galun, Eithan, Axelrod, Jonathan H., Sonnenblick, Amir
Publicado 2015

Chemotherapy-induced complement signaling modulates immunosuppression and metastatic relapse in breast cancer

por Monteran, Lea, Ershaid, Nour, Doron, Hila, Zait, Yael, Scharff, Ye’ela, Ben-Yosef, Shahar, Avivi, Camila, Barshack, Iris, Sonnenblick, Amir, Erez, Neta
Publicado 2022

Potential Refinement of Recurrence Score by pSTAT3 Status

por Grinshpun, Albert, Cohen, Yogev, Zick, Aviad, Kadouri, Luna, Hamburger, Tamar, Nisman, Benjamin, Allweis, Tanir M., Oprea, Gabriela, Peretz, Tamar, Uziely, Beatrice, Sonnenblick, Amir
Publicado 2022

The impact of tumor detection method on genomic and clinical risk and chemotherapy recommendation in early hormone receptor positive breast cancer

por Bar, Yael, Bar, Kfir, Itzhak, Itay, Niselbaum, Chen Shitrit, Dershowitz, Nachum, Shachar, Eliya, Weiss-Meilik, Ahuva, Golan, Orit, Wolf, Ido, Menes, Tehillah, Sonnenblick, Amir
Publicado 2021

Macrophages Upregulate Estrogen Receptor Expression in the Model of Obesity-Associated Breast Carcinoma

por Nahmias Blank, Daniela, Hermano, Esther, Sonnenblick, Amir, Maimon, Ofra, Rubinstein, Ariel M., Drai, Emmy, Maly, Bella, Vlodavsky, Israel, Popovtzer, Aron, Peretz, Tamar, Meirovitz, Amichay, Elkin, Michael
Publicado 2022

Integrative proteomic and gene expression analysis identify potential biomarkers for adjuvant trastuzumab resistance: analysis from the Fin-her phase III randomized trial

por Sonnenblick, Amir, Brohée, Sylvain, Fumagalli, Debora, Rothé, Françoise, Vincent, Delphine, Ignatiadis, Michael, Desmedt, Christine, Salgado, Roberto, Sirtaine, Nicolas, Loi, Sherene, Neven, Patrick, Loibl, Sibylle, Denkert, Carsten, Joensuu, Heikki, Piccart, Martine, Sotiriou, Christos
Publicado 2015

Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified Genes

por Maoz, Myriam, Devir, Michal, Inbar, Michal, Inbar-Daniel, Ziva, Sherill-Rofe, Dana, Bloch, Idit, Meir, Karen, Edelman, David, Azzam, Salah, Nechushtan, Hovav, Maimon, Ofra, Uziely, Beatrice, Kadouri, Luna, Sonnenblick, Amir, Eden, Amir, Peretz, Tamar, Zick, Aviad
Publicado 2019

Author Correction: Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified Genes

por Maoz, Myriam, Devir, Michal, Inbar, Michal, Inbar-Daniel, Ziva, Sherill-Rofe, Dana, Bloch, Idit, Meir, Karen, Edelman, David, Azzam, Salah, Nechushtan, Hovav, Maimon, Ofra, Uziely, Beatrice, Kadouri, Luna, Sonnenblick, Amir, Eden, Amir, Peretz, Tamar, Zick, Aviad
Publicado 2020

Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer

por Zahavi, Tamar, Salmon-Divon, Mali, Salgado, Roberto, Elkin, Michael, Hermano, Esther, Rubinstein, Ariel M., Francis, Prudence A., Di Leo, Angelo, Viale, Giuseppe, de Azambuja, Evandro, Ameye, Lieveke, Sotiriou, Christos, Salmon, Asher, Kravchenko-Balasha, Nataly, Sonnenblick, Amir
Publicado 2021

Second breast cancer: recurrence score results, clinicopathologic characteristics, adjuvant treatments, and outcomes—exploratory analysis of the Clalit registry

por Shachar, Shlomit S., Leviov, Michelle, Yerushalmi, Rinat, Drumea, Karen, Tokar, Margarita, Soussan-Gutman, Lior, Bareket-Samish, Avital, Sonnenblick, Amir, Ben-Baruch, Noa, Evron, Ella, Gal-Yam, Einav Nili, Paluch-Shimon, Shani, Bar-Sela, Gil, Goldvaser, Hadar, Stemmer, Salomon M.
Publicado 2023

Treatment inferred from mutations identified using massive parallel sequencing leads to clinical benefit in some heavily pretreated cancer patients

por Zick, Aviad, Peretz, Tamar, Lotem, Michal, Hubert, Ayala, Katz, Daniela, Temper, Mark, Rottenberg, Yakir, Uziely, Beatrice, Nechushtan, Hovav, Meirovitz, Amichai, Sonnenblick, Amir, Sapir, Eli, Edelman, David, Goldberg, Yael, Lossos, Alexander, Rosenberg, Shai, Fried, Iris, Finklstein, Ruth, Pikarsky, Eli, Goldshmidt, Hanoch
Publicado 2017